Trial Profile
Daylight photodynamic therapy for actinic keratoses: a multicentre study comparing two photosensitizers (BF-200 ALA versus MAL)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary) ; Methyl aminolevulinate
- Indications Actinic keratosis
- Focus Therapeutic Use
- 22 Apr 2015 New trial record